首页> 美国卫生研究院文献>Food Science and Biotechnology >Ginseng fermented by mycotoxin non-producing Aspergillus niger: ginsenoside analysis and anti-proliferative effects
【2h】

Ginseng fermented by mycotoxin non-producing Aspergillus niger: ginsenoside analysis and anti-proliferative effects

机译:人参毒素非生产黑曲霉发酵的人参:人参皂甙的分析和抗增殖作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Korean ginseng was fermented using Aspergillus niger (A. niger) FMB S494 and mycotoxins such as ochratoxin and fumonisin were not detected in the fermented ginseng. Protopanaxadiol-type ginsenosides such as glycosylated forms of Rb1, Rb2, Rc, and Rd decreased to 0 while compound K (cK) increased from 0 to 9 × 104 ppm in the extract of fermented ginseng. Protopanaxtriol-type ginsenosides such as Re and Rg1 decreased from 7.1 × 104 to 3.0 × 104 ppm and 6.8 × 104 to 4.6 × 104 ppm, respectively. Rg2 and Rh1 increased from 0 to 1.9 × 104 ppm and 0 to 2.7 × 104 ppm, respectively. We can demonstrate that A. niger was more inclined to transform protopanaxadiol-type ginsenosides. Moreover, fermented ginseng extract showed a dramatically enhanced anti-proliferative effect on human HT-29 cell line with a minimum effective concentration of about 1 µg/mL, which might be attributed to the high degree of biotransformation of ginsenosides, especially the high output of ginsenoside cK.
机译:使用黑曲霉FMB S494发酵高丽参,在发酵人参中未检出霉菌毒素,如曲霉毒素和伏马菌素。发酵人参提取物中原糖原二醇型人参皂苷(例如Rb1,Rb2,Rc和Rd的糖基化形式)降至0,而化合物K(cK)从0增加至9×10 4 ppm。诸如Re和Rg1之类的原托那三醇型人参皂苷从7.1×10 4 降至3.0×10 4 ppm和6.8×10 4 至4.6× 10 4 ppm。 Rg2和Rh1分别从0增加到1.9×10 4 ppm,从0增加到2.7×10 4 ppm。我们可以证明黑曲霉更倾向于转化人参二醇类人参皂苷。此外,发酵人参提取物对人HT-29细胞系具有显着增强的抗增殖作用,最低有效浓度约为1 µg / mL,这可能归因于人参皂苷的生物转化程度高,尤其是人参皂苷的高产量人参皂甙cK。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号